As filed with the U.S. Securities and Exchange Commission on May 28, 2021

Registration No. 333-

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM S-8

REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933

 

 

The Chemours Company
(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of
incorporation or organization)

 

46-4845564
(I.R.S. Employer
Identification No.)

 

 

1007 Market Street, Wilmington, Delaware 19801
(Address, including zip code, and telephone number, including
area code, of principal executive offices)

 

THE CHEMOURS COMPANY 2017 EQUITY AND INCENTIVE PLAN
(Full title of the plan)

 

 

David C. Shelton, Esq.

Senior Vice President, General Counsel &

Corporate Secretary
The Chemours Company
1007 Market Street, Wilmington, Delaware 19801
(Name and address of agent for service)

 

Telephone number, including area code, of agent for service: (302) 773-1000

 

Copies to:

 

Scott Lesmes, Esq.

Morrison & Foerster LLP

2100 L Street, NW, Suite 900

Washington, DC 20037

 

 

 

 

 

 


 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer

 

Accelerated filer

Non-accelerated filer

 

(Do not check if a smaller reporting company)

Smaller reporting company

Emerging growth company

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  

 

CALCULATION OF REGISTRATION FEE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Title of securities
to be registered

 

Amount to be
registered(1)

 

Proposed maximum
offering price per
share(2)

 

Proposed maximum
aggregate offering
price(2)

 

Amount of
registration fee(2)

 

Common Stock, par value $0.01

 

3,050,000

 

$33.90

 

$103,395,000

 

$11,280.39

 

 

 

(1)

Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers an indeterminate number of shares of common stock, par value $0.01 per share (“Common Stock”) of The Chemours Company (the “Registrant”), that may be issuable as a result of a stock split, stock dividend or similar transactions under The Chemours Company 2017 Equity and Incentive Plan, as amended and restated (the “Plan”).

 

 

 

(2)

Estimated solely for the purpose of determining the registration fee pursuant to Rule 457(c) and 457(h) under the Securities Act, the offering price and aggregate offering price are based on a price of $33.90 per share, which price is an average of the high and low prices of the Registrant’s Common Stock as reported on the New York Stock Exchange on May 24, 2021.

 

 



 

EXPLANATORY NOTE 

 

This Registration Statement on Form S-8 is filed by the Registrant relating to 3,050,000 shares of its Common Stock, issuable to eligible participants under the Plan, which Common Stock is in addition to the 19,000,000 shares of Common Stock registered on the Registrant’s Form S-8 filed with the Securities and Exchange Commission (the “Commission”) on May 3, 2017 (Commission File No. 333-217623) (the “Prior Registration Statement”).

 

This Registration Statement relates to securities of the same class as that to which the Prior Registration Statement relates, and is submitted in accordance with General Instruction E to Form S-8 regarding Registration of Additional Securities. Pursuant to General Instruction E of Form S-8, the contents of the Prior Registration Statement, to the extent relating to the registration of Common Stock issuable under the Plan, are incorporated herein by reference and made part of this Registration Statement, except as amended hereby.

 

PART II 

 

ITEM 8.    EXHIBITS. 

 

Exhibit
Number

 

Description

 

4.1

 

Registrant’s Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, as filed with the Commission on July 1, 2015).


 


4.2


 


Registrant’s Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K, as filed with the Commission on July 1, 2015).


 


5.1


 


Opinion of David C. Shelton, Esq.*


 


23.1


 


Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm.*


 


23.2


 


Consent of David C. Shelton, Esq. (included in Exhibit 5.1).*

 

 

 

 

 

24.1

 

Power of Attorney (included on signature page)*

 

 

 

 

 

99.1

 

The Chemours Company 2017 Equity and Incentive Plan, as amended and restated on April 28, 2021 (incorporated by reference to Appendix B to the Registrant’s definitive proxy statement for its Annual Meeting of Shareholders, as filed with the Commission on March 12, 2021).

*  Filed herewith.

 

 

 

 



 

SIGNATURES 

 

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Wilmington, State of Delaware, on May 28, 2021.

 

THE CHEMOURS COMPANY

 

By:

/s/ Sameer Ralhan

 

Sameer Ralhan

 

Senior Vice President, Chief Financial Officer

 

POWER OF ATTORNEY 

 

Each person whose signature appears below constitutes and appoints Sameer Ralhan and David C. Shelton, and each of them, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Registration Statement (including all pre-effective and post-effective amendments and registration statements filed pursuant to Rule 462 of the Securities Act of 1933), and to file the same with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.

 

/s/ Mark P. Vergnano

 

President, Chief Executive Officer, and Director

May 28, 2021

Mark P. Vergnano

 

(Principal Executive Officer)

 

 

 

 

 

/s/ Sameer Ralhan

 

Senior Vice President, Chief Financial Officer

May 28, 2021

Sameer Ralhan

 

(Principal Financial Officer)

 

 

 

 

 

/s/ Matthew S. Abbott

 

Vice President and Controller

May 28, 2021

Matthew S. Abbott

 

(Principal Accounting Officer)

 

 

 

 

 

/s/ Richard H. Brown

 

Chairman of the Board

May 28, 2021

Richard H. Brown

 

 

 

 

 

 

 

/s/ Curtis V. Anastasio

 

Director

May 28, 2021

Curtis V. Anastasio

 

 

 

 

 

 

 

/s/ Bradley J. Bell

 

Director

May 28, 2021

Bradley J. Bell

 

 

 

 

 

 

 

/s/ Mary B. Cranston

 

Director

May 28, 2021

Mary B. Cranston

 

 

 

 

 

 

 

/s/ Curtis J. Crawford

 

Director

May 28, 2021

Curtis J. Crawford

 

 

 

 

 

 

 

/s/ Dawn L. Farrell

 

Director

May 28, 2021

Dawn L. Farrell

 

 

 

 

 

 

 

/s/ Erin N. Kane

 

Director

May 28, 2021

Erin N. Kane

 

 

 

 

 

 

 

/s/ Sean D. Keohane

 

Director

May 28, 2021

Sean D. Keohane

 

 

 

 

 

Chemours (NYSE:CC)
Historical Stock Chart
From Jun 2021 to Jul 2021 Click Here for more Chemours Charts.
Chemours (NYSE:CC)
Historical Stock Chart
From Jul 2020 to Jul 2021 Click Here for more Chemours Charts.